Evidence map›Paper›PMID 41458953›Full record

ArticleFrontiers in pharmacology2025

Medication adherence in the elderly population with chronic diseases: a factor analysis.

Doris Cardona, Valeria Santacruz-Restrepo, Alejandra Rendón-Montoya, Juliana Madrigal-Cadavid, Alejandra Segura-Cardona, Jorge Iván Estrada-Acevedo

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Doris CardonaIndependent Researcher in a Postdoctoral Fellowship, Medellín, Colombia.
Valeria Santacruz-RestrepoYoung Researcher and Innovator. HelPharma, Medellín, Colombia.
Alejandra Rendón-MontoyaPharmacoepidemiology and Risk Management Group, HelPharma, Medellín, Colombia.
Juliana Madrigal-CadavidPharmacoepidemiology and Risk Management Group, HelPharma, Medellín, Colombia.
Alejandra Segura-CardonaFaculty of Psychology, Universidad CES, Medellín, Colombia.
Jorge Iván Estrada-AcevedoPharmacoepidemiology and Risk Management Group, HelPharma, Medellín, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Elderly adults suffer from one or more high-cost chronic diseases, consume more medications; therefore, adherence to prescribed treatments is essential to ensure effective management of these conditions. Objective: To identify the characteristics that most significantly affect medication adherence among older adults in Colombia. Methods: This was a quantitative, cross-sectional study with an analytical intent based on all medical records, medication orders, dispensing, and pharmacotherapeutic follow-up of patients over 65 years of age treated by a pharmaceutical manager between 2019 and 2025. Medication adherence was related to certain sociodemographic, clinical, and pharmacological characteristics. The analyses were univariate, bivariate, and multivariate, using an explanatory model to control for potentially confounding variables (with a significance level greater than 5%), crude and adjusted proportion ratios, 95% confidence intervals, and factor analysis using the principal component method. Results: A total of 42,601 records of older adults were evaluated. Medication non-adherence was 5.9%, and pharmacological factors were the most statistically associated, mainly problems of inappropriate use; suffering from various chronic diseases with various pharmacological regimens, coupled with administrative inefficiencies and inappropriate use of medications, are variables that influence non-adherence. Conclusion: From a public health perspective, medication adherence in older adults is a determinant of health outcomes and a key factor for the sustainability of health systems. Optimizing adherence requires comprehensive interventions framed within public policies that guarantee continuity of care, timely access to medications, and the strengthening of interdisciplinary teams. Recognizing adherence as a collective, and not just an individual, challenge is essential to reducing preventable complications, lowering hospitalization rates, and improving the quality of life of an increasingly aging population.

Indexed as

agingchronic diseasehealth and wellbeingmedication adherencemedication therapy managementSDG3universal health coverage

Identifiers

PMID41458953
PMCPMC12741845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.